Literature DB >> 7933231

Morphology of prostate cancer: the effects of multifocality on histological grade, tumor volume and capsule penetration.

G J Miller1, J M Cygan.   

Abstract

A series of 151 radical prostatectomy specimens were subjected to whole-mount analysis. Features examined included histological grade, tumor volume, pathological stage and multifocality. Only 43.7% of the prostates contained a single carcinoma, 31.1% had 2 separate foci and the remaining 25.2% contained 3 to 6 tumors. Multifocality was greatest among tumors with the lowest mean volumes. Tumors with volumes of less than 3 cc were found in all grades (Gleason sums of 2 through 10). The highest volume tumors were those of intermediate grade (Gleason sums 4 through 8). Among tumors with volumes of less than 1 cc 70% that were confined within the prostatic capsule had Gleason sums of 4 or less. However, tumors with volumes of less than 3 cc that had invaded through the prostatic capsule were nearly equally divided between Gleason sums of 2, 3 or 4 and those of 5, 6 or 7. While studies examining the largest tumor per prostate have suggested that histological grade and volume are closely related, our results indicate that this is not necessarily the case. Furthermore, it is clear that tumors need not acquire either large volume or high grade before they can become locally invasive. It is likely, therefore, that the prediction of prognosis for patients with prostatic cancer is greatly influenced by tumor multifocality.

Entities:  

Mesh:

Year:  1994        PMID: 7933231     DOI: 10.1016/s0022-5347(17)32368-6

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  32 in total

Review 1.  Methods for volume assessment of prostate cancer.

Authors:  Heinz-Peter Schlemmer; Stefan Corvin
Journal:  Eur Radiol       Date:  2004-02-06       Impact factor: 5.315

2.  Anterior tumors of the prostate: diagnosis and significance.

Authors:  Priya N Werahera; E David Crawford; Francisco G La Rosa; Kathleen C Torkko; Beth Schulte; Holly T Sullivan; Adrie van Bokhoven; M Scott Lucia; Fernando J Kim
Journal:  Can J Urol       Date:  2013-10       Impact factor: 1.344

3.  Temporal changes in the pathologic assessment of prostate cancer.

Authors:  M Scott Lucia; Adrie van Bokhoven
Journal:  J Natl Cancer Inst Monogr       Date:  2012-12

4.  Correlation of digital rectal examination, prostate specific antigen, and transrectal ultrasound in prostate carcinoma in African Americans.

Authors:  R I Sibley; A F Sibley
Journal:  J Natl Med Assoc       Date:  1997-05       Impact factor: 1.798

5.  Re-evaluating the concept of "dominant/index tumor nodule" in multifocal prostate cancer.

Authors:  Cheng Cheng Huang; Fang-Ming Deng; Max X Kong; Qinhu Ren; Jonathan Melamed; Ming Zhou
Journal:  Virchows Arch       Date:  2014-03-12       Impact factor: 4.064

Review 6.  Genomic and phenotypic heterogeneity in prostate cancer.

Authors:  Michael C Haffner; Wilbert Zwart; Martine P Roudier; Lawrence D True; William G Nelson; Jonathan I Epstein; Angelo M De Marzo; Peter S Nelson; Srinivasan Yegnasubramanian
Journal:  Nat Rev Urol       Date:  2020-12-16       Impact factor: 14.432

7.  Intratumoral and Intertumoral Genomic Heterogeneity of Multifocal Localized Prostate Cancer Impacts Molecular Classifications and Genomic Prognosticators.

Authors:  Lei Wei; Jianmin Wang; Erika Lampert; Simon Schlanger; Adam D DePriest; Qiang Hu; Eduardo Cortes Gomez; Mitsuko Murakam; Sean T Glenn; Jeffrey Conroy; Carl Morrison; Gissou Azabdaftari; James L Mohler; Song Liu; Hannelore V Heemers
Journal:  Eur Urol       Date:  2016-07-21       Impact factor: 20.096

Review 8.  Pathologic basis of focal therapy for early-stage prostate cancer.

Authors:  Vladimir Mouraviev; Janice M Mayes; Thomas J Polascik
Journal:  Nat Rev Urol       Date:  2009-04       Impact factor: 14.432

Review 9.  Active surveillance and radical therapy in prostate cancer: can focal therapy offer the middle way?

Authors:  Hashim Uddin Ahmed; Mark Emberton
Journal:  World J Urol       Date:  2008-08-14       Impact factor: 4.226

10.  Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer.

Authors:  Wennuan Liu; Sari Laitinen; Sofia Khan; Mauno Vihinen; Jeanne Kowalski; Guoqiang Yu; Li Chen; Charles M Ewing; Mario A Eisenberger; Michael A Carducci; William G Nelson; Srinivasan Yegnasubramanian; Jun Luo; Yue Wang; Jianfeng Xu; William B Isaacs; Tapio Visakorpi; G Steven Bova
Journal:  Nat Med       Date:  2009-04-12       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.